Dr. Martin Gleave, M.D.
Department of Surgery, UBC
And Director, Clinical Research
The Prostate Centre, Vancouver General Hospital
will be addressing the Vancouver Institute on October 30, 2004 at 8:15 p.m., Lecture Hall No. 2 in the Woodward Instructional Resources Centre, University of British Columbia.
From Mice to Men:
Translating Discoveries in Prostate Cancer Research
Into Improved Patient Care
Dr. Gleave's current research focuses on the study of cellular and molecular mechanisms that mediate progression of prostate cancer to its lethal stage of androgen independence, and on the use of this information to develop integrated multi-modality therapies that specifically target these mechanisms. He has published more than 100 peer-reviewed papers, and currently has more that $20M in peer reviewed funding. He is a recipient of many awards, most recently the prestigious NCIC William Rawles Award for contributions to cancer control in Canada. As Founder and CSO of OncoGenex, he is familiar with role of industry in translating preclinical observations into the clinic. He is active in clinical trials across Canada and is Chairman of the National Cancer Institute of Canada GU Clinical Trials Group, and Chairman of the Canadian Uro-Oncology Group.
Fall Program 2004
Sep 18,
Sep 25,
Oct 2,
Oct 16,
Oct 23,
Oct 30,
Monday Nov 8,
Nov 13,
Nov 20,
Nov 27,
Dec 4.
